Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |